News

News

GTP new operation

GemPharmatech and UC Davis Sign Agreement to Distribute Mouse Models in the US to Better Serve US Academic and Pre-Clinical R&D Communities

GemPharmatech (GemPharmatech Co. Ltd., “GPT”) announced the agreement for UC Davis Mouse Biology Program to provide services to re-animate, cryopreserve and ship live mice to GemPharmatech customers in the US.

Read more at: businesswire.com

GTP new operation

SARS-COV-2 MPRO inhibitors with antiviral activity in a transgenic mouse model

Recent breakthrough paper in Science Magazine discovers possible new therapeutics for SARS-CoV-2 using our the GemPharmatech humanized ACE2 models for COVID research. Congrats to authors. Please contact us to find out more about the hACE2 model at globalservice@gempharmatech.com.

Read the full article at: science.sciencemag.org

Download the supplemental materials.

GTP new operation

GemPharmatech Opens New Operations in United States to House More Than 6000 Research Mouse Models

WILMINGTON, Del.--(BUSINESS WIRE)--GemPharmatech (GPT) Co., Ltd. announced the establishment of new operations to house more than 6000 mouse models in Massachusetts and California. GPT is a leading global provider of laboratory animals including cKO/KO and humanized mouse models as research tools supporting drug discovery and pre-clinical research and development. Currently, GPT has a large collection of 15,000+ mouse models and has four existing facilities worldwide.

Read more at: businesswire.com

Appointment CEO